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Abstract
Background: The aim of this study was to determine the effects of creatine supplementation on kidney function in
resistance-trained individuals ingesting a high-protein diet.
Methods: A randomized, double-blind, placebo-controlled trial was performed. The participants were randomly
allocated to receive either creatine (20 g/d for 5 d followed by 5 g/d throughout the trial) or placebo for 12 weeks.
All of the participants were engaged in resistance training and consumed a high-protein diet (i.e., ≥ 1.2 g/Kg/d).
Subjects were assessed at baseline (Pre) and after 12 weeks (Post). Glomerular filtration rate was measured by
51Cr-EDTA clearance. Additionally, blood samples and a 24-h urine collection were obtained for other kidney
function assessments.
Results: No significant differences were observed for 51Cr-EDTA clearance throughout the trial (Creatine: Pre 101.42 ±
13.11, Post 108.78 ± 14.41 mL/min/1.73m2; Placebo: Pre 103.29 ± 17.64, Post 106.68 ± 16.05 mL/min/1.73m2; group x
time interaction: F = 0.21, p = 0.64). Creatinine clearance, serum and urinary urea, electrolytes, proteinuria, and
albuminuria remained virtually unchanged.
Conclusions: A 12-week creatine supplementation protocol did not affect kidney function in resistance-trained healthy
individuals consuming a high-protein diet; thus reinforcing the safety of this dietary supplement.
Trial registration: ClinicalTrials.gov NCT01817673
Keywords: Glomerular filtration rate, 51Cr-EDTA clearance, Side effects
Background
Creatine supplementation has been recognized as one of
the most efficient dietary supplements capable of increasing
muscle strength and lean mass [1], as well as high-intensity
exercise performance [2]. However, the indiscriminate
use of this supplement has raised concerns regarding its
safety, especially in relation to kidney function [3].
Despite the increasing number of publications show-
ing that creatine supplementation may not affect kidney
function in humans [4-10], it has been recommended
that the chronic effects of creatine supplementation
should be better examined in some specific populations
[3]. In this regard, there is an empirical claim that creatine
supplementation might pose a risk at those consuming
protein in excess. In fact, there is compelling evidence in-
dicating that high-protein diets can accelerate renal deteri-
oration in individuals with chronic kidney disease [11],
although it is unknown whether this holds true in healthy
persons [12].
Resistance-trained practitioners often consume a high-
protein diet along with creatine supplements in an attempt
to enhance power/strength and lean mass. The alleged
“kidney overload” caused by creatine (and its by-product
creatinine) and excessive protein ingestion merits further
investigation. Therefore, the purpose of this study was to
examine the effects of creatine supplementation on kidney
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function in resistance-trained individuals consuming a
high-protein diet. In most of the previous human studies
involving creatine supplementation, kidney function was
assessed via serum creatinine or its derivative equations.
However, the spontaneous conversion of creatine into
creatinine [13] may falsely suggest decreased kidney
function in creatine-supplemented individuals [8]. To
overcome this potential drawback, we used a gold
standard method - 51Chromium-ethylenediamine tetra-
acetic acid (51Cr-EDTA) clearance - to accurately measure
glomerular filtration rate in this study.
Methods
Subjects
Young healthy males who regularly engaged in resistance
training for at least 1 year and were ingesting a high-
protein diet (≥ 1.2 g/Kg/d; which is a usual prescription to
resistance-trained practitioners [14]) were eligible to par-
ticipate. The exclusion criteria included: vegetarian diet,
use of creatine supplements in the past 6 months, chronic
kidney disease, and use of anabolic steroids. The partici-
pants were advised to maintain their habitual diet. Partici-
pants’ characteristics are presented in Table 1. The study
was approved by the Ethical Advisory Committee from
the School of Physical Education and Sport, University of
Sao Paulo. All of the participants signed the informed
consent. This trial was registered at clinicaltrials.gov as
NCT01817673.
Experimental protocol
A 12-week, double-blind, randomized, placebo-controlled
trial was conducted between July 2011 and February 2013
in Sao Paulo, Brazil. The participants were randomly
assigned to receive either creatine or placebo in a double-
blind fashion. All of the participants continued with their
usual resistance training routines throughout the study.
The participants were assessed at baseline (Pre) and after
12 weeks (Post). 51Cr-EDTA clearance was performed to
measure the glomerular filtration rate. Additionally, blood
samples and twenty-four-hour urine collection were
obtained following a 12-h overnight fasting for kidney
function assessments. Dietary intake was assessed by 7-day
food diaries. The participants were asked to refrain from
strenuous physical activity 24 h prior to the pre- and post-
tests. Food intake was assessed by 7-day food diaries. This
method consists of the listing of foods and beverages con-
sumed during 7 consecutive days. Energy and macronutri-
ents were analyzed by the Dietpro® 5i software (Sao Paulo,
Brazil).
Creatine supplementation protocol and blinding procedure
The creatine group received creatine monohydrate (20 g/d
for 5 d followed by 5 g/d throughout the trial). The pla-
cebo group received the same dosage of dextrose. The par-
ticipants were advised to consume their supplements
preferably along with meals (e.g., breakfast, lunch, after-
noon snack, and dinner). The supplement packages were
coded so that neither the investigators nor the participants
were aware of the contents until the completion of the
analyses. In order to verify the purity of the creatine used,
a sample was analyzed by high-performance liquid chro-
matography (HPLC). This established 99.9% of purity,
with no other peaks detected (creatinine, dicyandiamide,
and cyclocreatine < 0.01%).
51Cr-EDTA clearance
After a 24h-protein-restricted diet and a 12-h overnight
fasting, the participants were admitted to the clinical re-
search center at 7:00 a.m., where they rested in a supine
position with an indwelling polyethylene catheter inserted
into a cubital vein in both arms. A single dose of 3.7 MBq
(100 μCi) of the 51Cr-EDTA tracer, in a volume of 1 ml
was injected intravenously in the right arm. The catheter
was flushed through with 10 ml of saline. Accurately
timed 10-ml blood-samples were drawn into a heparinized
tube from the opposite arm at 4 and 6 h after the injec-
tion. The plasma disappearance curve was designed using
the results of these time-points. To measure the radioiso-
tope activity, the blood samples were centrifuged at 1500 g
for 10 min and 3 ml of plasma was measured in a well-
calibrated counter (Genesys Genii™, LabLogic Systems Inc,
Brandon, Florida, USA) for the energy of chromium-51
(320 keV). Each sample, including 3 ml of standard
solution taken as an aliquot from 3.7 MBq (100 μCi)
51Cr-EDTA diluted to 500 mL in saline, was counted
for 5 min. The plasma clearance rate was calculated by
the slope-intercept method with a single-compartment
model, which assumes that the tracer spreads out im-
mediately after injection in its volume of distribution.
The Brochner–Mortensen method was used for correcting
systematic errors of the slope-intercept technique accor-
ding to the following equation:
Clc ¼ 0:9908  Clnc−0:001218  Clnc2
Table 1 Participants’ characteristics
Creatine (n = 12) Placebo (n = 14)
Age (years) 24 (3) 27 (5)
Height (m) 1.79 (0.08) 1.78 (0.05)
Weight (Kg) 80.4 (10.3) 78.4 (12.4)
BMI (Kg/m2) 24.8 (1.6) 24.7 (2.9)
Training experience (years) 5 (2) 7 (3)
Training frequency (sessions
per week)
5 (1) 4 (1)
Data expressed as mean (standard deviation).
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where Clc is the clearance corrected for the first exponen-
tial and Clnc is the non-corrected clearance. Systematic
errors caused by an abnormal radioisotope distribution
were corrected using the Groth method. 51Cr-EDTA
clearance was also corrected for 1.73 m2 body surface
area. The coefficient of variation (CV) for 51Cr-EDTA
clearance was 9.7%.
Blood and urinary analyses
Blood samples were obtained from an antecubital vein,
following a 12-h overnight fasting. Participants followed
their normal diet consumption during the 24-h urine
collection. Urine samples were stored at approximately
4°C. Both blood and urinary measurements were
performed in the morning. Creatinine was determined
using Jaffe’s kinetic method. Urinary and serum sodium
and potassium were assessed by using a flame photom-
eter (FP8800, Kruss®, Hamburg, Germany). Urea was
assessed by an UV-kinetic method. Albuminuria was
determined by nephelometry and proteinuria was mea-
sured through the benzethonium chloride method.
All of the samples were analyzed in duplicate and the
CV were 2.0, 2.2, 1.1, 2.1, 2.3, 5.3, 24.5, and 16.4% for
serum creatinine, serum sodium, serum potassium, serum
urea, proteinuria, albuminuria, urinary sodium, and urinary
potassium, respectively.
Statistical analysis
It was determined that 24 participants is necessary to
provide 80% power (5% significance, two-tailed) to de-
tect a 20% reduction in the 51Cr-EDTA clearance. In
order to account for mid-trial withdrawals, we enlarged
our study sample size to 46 participants.
Data were tested by a Mixed Model with Kenward-
Roger adjustment for unbalanced group sizes, using the
software SAS 9.2 (SAS Institute Inc., Cary, NC, USA).
Group (creatine and placebo) and time (Pre and Post)
were considered as fixed factors and participants were
defined as a random factor. A post hoc test adjusted by
Tukey was planned to be used whenever a significant
F-value was detected. The between-group difference in the
ratio of participants who had reduction in the 51Cr-EDTA
clearance was tested by the Chi-square (χ2) test. Signifi-
cance level was previously set at p < 0.05. Data are
presented as mean and standard deviation.
Results
Flux of participants
The flux of participants is shown in Figure 1. A total of
115 volunteers who were screened for participation and
69 volunteers did not meet the inclusion criteria. The
remaining 46 participants were randomly assigned to
either the creatine (n = 23) or the placebo (n = 23) group.
Afterwards, 15 participants withdrew for personal rea-
sons (8 from the creatine group and 7 from the placebo
group). Additionally, 5 participants (3 from the creatine
group and 2 from the placebo group) did not attend the
post-intervention assessment; hence, they were removed
from the analysis. Therefore, 12 participants in the creat-
ine group and 14 participants in the placebo group were
analyzed (n = 26).
Food intake
Table 2 shows the food intake data. Protein intake
ranged from 1.2 to 3.1 g/Kg/d. Diet remained unchanged
throughout the study.
Kidney function assessments
Figure 2 shows the data regarding the 51Cr-EDTA clear-
ance. There were no significant differences between
groups at Pre or Post (group × time interaction: F = 0.21,
p = 0.64). In the creatine group, 2 out of 12 participants
Figure 1 Fluxogram of participants.
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had a decrease in the 51Cr-EDTA clearance, whereas 6
out of 14 participants experienced reduction in the
51Cr-EDTA clearance in the placebo group (P(χ2 > 2.081) =
0.149).
Table 3 presents the data regarding albuminuria, pro-
teinuria, serum and urinary sodium and potassium,
serum urea and serum creatinine. There were no signifi-
cant differences between groups for any of the parameters
(p > 0.05). None of the participants had either albuminuria
or proteinuria.
Discussion
The present results are in agreement with other investi-
gations that have demonstrated the safety of creatine
supplementation on kidney function in distinct popula-
tions [4-9]. However, most of these studies estimated
glomerular filtration rate by using serum endogenous
markers, which are widely used in clinical practice but
potentially susceptible to methodological errors. For in-
stance, serum creatinine and its derivative equations are
influenced by dietary intake, particularly by creatine-
containing foods or supplements. Upon the ingestion of
creatine, one may expect an increase in serum creatin-
ine, since creatine is spontaneously and irreversibly
converted into creatinine. As such, a false positive
diagnosis of a decreased kidney function may occur in
creatine-supplemented individual when only serum cre-
atinine data are taken into consideration. Although
serum creatinine was not significantly elevated in the
current study, previous observations from our group [8]
and others [15] support the inaccuracy of creatinine-
based markers in the evaluation of kidney function in
creatine-supplemented individuals. To circumvent this
potential bias, we measured glomerular filtration rate
using the gold-standard technique 51Cr-EDTA clearance,
which allowed us to properly conclude that creatine sup-
plementation did not affect kidney function in this
study.
Table 2 Food intake before (Pre) and after 12 weeks (Post) of either creatine or placebo supplementation in resistance-
trained individuals consuming a high-protein diet
Creatine (n = 12) Placebo (n = 14)
Variable Pre Post Pre Post P (group x time interaction)
Protein (g) 154 (45) 154 (39) 133 (36) 120 (39) 0.54
Carbohydrate (g) 283 (70) 322 (96) 271 (92) 272 (124) 0.49
Lipid (g) 84 (23) 91 (27) 98 (31) 86 (31) 0.23
Protein (%) 25 (5) 23 (5) 22 (4) 22 (5) 0.65
Carbohydrate (%) 45 (6) 47 (9) 43 (10) 47 (6) 0.58
Lipid (%) 30 (6) 30 (8) 35 (8) 32 (6) 0.48
Total Energy (Kcal) 2506 (530) 2725 (522) 2518 (544) 2368 (781) 0.29
Protein/ body weight (g/Kg) 1.9 (0.5) 1.9 (0.5) 1.7 (0.5) 1.6 (0.5) 0.53
Data expressed as mean (standard deviation). There were no significant differences between groups at baseline. No significant within- or between-group
differences were noted.
Figure 2 51Cr-EDTA clearance before (Pre) and after 12 weeks
(Post) of either creatine (n = 12) or placebo (n = 14)
supplementation in resistance-trained individuals consuming a
high-protein diet. Panel A: individual data. Panel B: mean ±
standard deviation. No significant difference between groups across
time (group x time interaction) was observed (F = 0.21, p = 0.64).
Note: Conversion factors for units: glomerular filtration rate in
mL/min/1.73 m2 to mL/s/1.73 m2, ×0.01667.
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Applying the above mentioned technique, we previ-
ously showed that 35 days of creatine supplementation
did not alter kidney function in a 20-year-old man with
a single kidney [16]. Moreover, we reported that 3
months of creatine supplementation had no deleterious
effect on kidney function in post-menopausal women
[9] and in type-2 diabetic patients [17], corroborating
the safety of this supplement. The present data extend
this notion to typical creatine consumers, suggesting
that healthy resistance-trained individuals can “deal”
with creatine supplementation even in combination
with a higher level of protein intake (considering the
Recommended Dietary Intake (RDI) of 0.8 g/Kg/d). In
consonance with our findings, a few cross-sectional
studies have shown no significant differences in kidney
function between higher and lower protein consumers
[18,19]. In fact, given the human habituation to the
high-nitrogenous diet throughout the span of evolution,
these findings might not be considered unexpected. Yet,
further prospective studies must explore the impact of
chronic nitrogenous-rich diets upon kidney function in
healthy individuals.
This study is not without limitations. First, the follow-
up of this study is too short, precluding any definitive
conclusions. Originally, this trial was designed to cover a
12-month period. However, a drastic withdrawal rate
forced us to reduce the follow-up period. Therefore, trials
of longer treatment duration are warranted. Second, we
selected recreationally trained participants to increase the
ecological validity of this study, since this population is
thought to be the largest consumer of creatine supple-
ments. However, it is possible that highly-trained athletes
taking anabolic steroids and under exhaustive resistance
training regimens may experience a differential response
to creatine supplementation. Finally, it is worth noting
that all of the individuals were apparently healthy, so that
these data cannot be extrapolated to individuals with, or at
risk of, chronic kidney diseases. In such conditions, cre-
atine users must be systematically monitored for kidney
function.
Conclusions
Three months of creatine supplementation did not have
a detrimental effect on kidney function in resistance-
trained practitioners consuming a high-protein diet
(i.e., ≥ 1.2 g/Kg/d).
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Table 3 Kidney function parameters before (Pre) and after 12 weeks (Post) of either creatine or placebo
supplementation in resistance-trained individuals consuming a high-protein diet
Creatine (n = 12) Placebo (n = 14)
Variable Pre Post Pre Post P (group x time interaction)
Albuminuria (mg/24 h) 19 (38) 15 (28) 8 (7) 4 (2) 0.99
Proteinuria (g/24 h) 0.14 (0.11) 0.14 (0.10) 0.10 (0.05) 0.10 (0.07) 0.83
Urinary potassium (mEq/24 h) 65 (24) 59 (22) 68 (24) 65 (19) 0.86
Urinary sodium (mEq/24 h) 231 (56) 226 (91) 195 (65) 191 (52) 0.99
Serum potassium (mEq/L) 4 (0.3) 4 (0.4) 5 (0.4) 4 (0.4) 0.26
Serum sodium (mEq/L) 141 (3) 141 (2) 142 (3) 141 (4) 0.53
Serum creatinine (mg/dL) 1.1 (0.1) 1.2 (0.2) 1.0 (0.1) 1.1 (0.1) 0.30
Serum urea (mg/dL) 41.7 (10.7) 39.2 (11.7) 33.3 (6.7) 33.4 (7.2) 0.63
Data expressed as mean (standard deviation). There were no significant differences between groups at baseline. No significant within- or between-group
differences were noted. Note: Conversion factors for units: serum creatinine in mg/dL to mol/L, ×88.4; serum urea in mg/dL to mmol/L, ×0.166; glomerular
filtration rate in mL/min/1.73 m2 to mL/s/1.73 m2, ×0.01667.
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